Prostate Diseases
  Prostate Cancer
Benign Prostatic Hyperplasia (BPH)
Prostatitis
Doc, I've Been Wondering...
Think of Screening as a Good Thing


  Bayer Global
  Bayer Corporate - USA
general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 
Understanding Prostate Diseases
Prostatitis - References		    
     
 
  1. American Foundation for Urologic Disease. Prostate Health: Basic Facts for Better Health. What Every Man Should Know. page 14.
  2. National Institutes of Health, National Cancer Institute. Understanding Prostate Changes: A Health Guide for Men, 2004, page 5.
  3. National Institutes of Health, National Cancer Institute. Understanding Prostate Changes: A Health Guide for Men, 2004, page 5.
  4. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  5. American Foundation for Urologic Disease. Prostate Health: Basic Facts for Better Health. What Every Man Should Know. Page 16.
  6. American Foundation for Urologic Disease. Prostate Health: Basic Facts for Better Health. What Every Man Should Know. Page 16.
  7. American Foundation for Urologic Disease. Prostate Health: Basic Facts for Better Health. What Every Man Should Know. Page 16.
  8. American Foundation for Urologic Disease. Prostate Health: Basic Facts for Better Health. What Every Man Should Know. Page 16.
  9. American Foundation for Urologic Disease. Prostate Health: Basic Facts for Better Health. What Every Man Should Know. Page 15.
  10. American Foundation for Urologic Disease. Prostate Health: Basic Facts for Better Health. What Every Man Should Know. Page 17.
  11. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  12. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  13. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  14. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  15. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  16. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  17. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  18. Prostatitis at the Prostate Center: Prostatitis Definition and Classification. Columbia University Department of Urology. Available at: http://cpmcnet.columbia.edu/dept/urology/prostatitis.html. Accessed January 1, 2005.
  


Back

Important Safety Considerations
Viadur should not be used by patients who are allergic to the drug leuprolide. Viadur should not be used by women or children and was not studied in women or children.
Viadur, like other similar medications, causes a temporary increase of testosterone in the blood during the first week of treatment. During this initial period, patients may experience worsening of symptoms or onset of new symptoms including bone pain, nervous system disturbances, blood in the urine, difficulty urinating, and spinal cord compression.
During treatment, the most common side effects reported throughout the body were hot flashes, lack of energy, breast enlargement, depression, and sweating. The most common side effects reported where the implant was inserted in the arm were bruising and burning.

See Your Healthcare Provider
Remember, your doctor or health care provider is the single best source of information regarding you and your health. Please consult your doctor if you have any questions about your health, your symptoms, or your medication.

This information does not take the place of your doctor’s advice or instructions but should help answer some of the questions you might have about prostate cancer therapies.

Distributed and Marketed by:
Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.